Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.

M Degerman Gunnarsson; M Lindau; Alexander Santillo; A Wall; H Engler; L Lannfelt; H Basun; L Kilander

doi:10.1159/000356273

Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.

M Degerman Gunnarsson, M Lindau, Alexander Santillo, A Wall, H Engler, L Lannfelt, H Basun, L Kilander

Research output: Contribution to journal › Article › peer-review

235 Downloads (Pure)

Abstract

There is an overlap regarding Pittsburgh compound B (PIB) retention in patients clinically diagnosed as Alzheimer's disease (AD) and non-AD dementia. The aim of the present study was to investigate whether there are any differences between PIB-positive and PIB-negative patients in a mixed cohort of patients with neurodegenerative dementia of mild severity regarding neuropsychological test performance and regional cerebral glucose metabolism measured with [(18)F]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET).

Original language	English
Pages (from-to)	472-481
Journal	Dementia and Geriatric Cognitive Disorders Extra
Volume	3
Issue number	1
DOIs	https://doi.org/10.1159/000356273
Publication status	Published - 2013

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Department of Psychogeriatrics (013304000)

Subject classification (UKÄ)

Psychiatry
Geriatrics

Access to Document

10.1159/000356273

Karger_Degerman_et_al

http://www.ncbi.nlm.nih.gov/pubmed/24516415?dopt=Abstract

Cite this

@article{b8b4aaff5fd14f2c972f97e343d8176d,

title = "Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.",

abstract = "There is an overlap regarding Pittsburgh compound B (PIB) retention in patients clinically diagnosed as Alzheimer's disease (AD) and non-AD dementia. The aim of the present study was to investigate whether there are any differences between PIB-positive and PIB-negative patients in a mixed cohort of patients with neurodegenerative dementia of mild severity regarding neuropsychological test performance and regional cerebral glucose metabolism measured with [(18)F]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET).",

author = "{Degerman Gunnarsson}, M and M Lindau and Alexander Santillo and A Wall and H Engler and L Lannfelt and H Basun and L Kilander",

note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Department of Psychogeriatrics (013304000)",

year = "2013",

doi = "10.1159/000356273",

language = "English",

volume = "3",

pages = "472--481",

journal = "Dementia and Geriatric Cognitive Disorders Extra",

issn = "1664-5464",

publisher = "Karger",

number = "1",

}

TY - JOUR

T1 - Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.

AU - Degerman Gunnarsson, M

AU - Lindau, M

AU - Santillo, Alexander

AU - Wall, A

AU - Engler, H

AU - Lannfelt, L

AU - Basun, H

AU - Kilander, L

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Department of Psychogeriatrics (013304000)

PY - 2013

Y1 - 2013

N2 - There is an overlap regarding Pittsburgh compound B (PIB) retention in patients clinically diagnosed as Alzheimer's disease (AD) and non-AD dementia. The aim of the present study was to investigate whether there are any differences between PIB-positive and PIB-negative patients in a mixed cohort of patients with neurodegenerative dementia of mild severity regarding neuropsychological test performance and regional cerebral glucose metabolism measured with [(18)F]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET).

AB - There is an overlap regarding Pittsburgh compound B (PIB) retention in patients clinically diagnosed as Alzheimer's disease (AD) and non-AD dementia. The aim of the present study was to investigate whether there are any differences between PIB-positive and PIB-negative patients in a mixed cohort of patients with neurodegenerative dementia of mild severity regarding neuropsychological test performance and regional cerebral glucose metabolism measured with [(18)F]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET).

U2 - 10.1159/000356273

DO - 10.1159/000356273

M3 - Article

SN - 1664-5464

VL - 3

SP - 472

EP - 481

JO - Dementia and Geriatric Cognitive Disorders Extra

JF - Dementia and Geriatric Cognitive Disorders Extra

IS - 1

ER -

Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.

Abstract

Bibliographical note

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this